ANRS Task Force HBV Cure

The HBV Cure working group aims to contribute actively to the identification of new therapeutic targets and antiviral molecules for a functional cure of the HBV virus.

Last updated on 24 April 2024

In brief

The HBV Cure working group aims to contribute actively to the identification of new therapeutic targets and antiviral molecules for a functional cure of the HBV virus.

One of the priorities is also to support basic research with translational and clinical research.

Main tasks

– To promote ambitious and innovative research into HBV Cure in France and internationally;

– Leading scientific discussions within the consortium in order to incubate and promote cutting-edge research programmes, combining basic, translational, clinical, social science and public health research;

– Communicate on the Taskforce’s programme and achievements and disseminate knowledge on the HBV Cure theme in order to serve the global perspective of eliminating HBV worldwide.

Activities

  1. The HBV Cure working group leads a network of researchers and clinicians whose aim is to give visibility to and discuss the latest international advances in basic and translational research on the HBV virus.
  2. Each year, this working group organises an international workshop on the theme of HBV cure, reflecting the ideas identified and prioritised at the annual meetings of the HBV Cure Task Force.
  3. HBV treatments – Functional recovery HBV – Basic and translational research HBV.

Leadership


Fabien Zoulim
Inserm U1052, CHU Lyon – Lyon Cancer Research Centre

Contacts ANRS MIE

Chloé Duquesnay (Coordinatrice des instances scientifiques)

Tounès Saïdi (Cheffe de projet)